Monoclonal antibodies directed against rat tumor antigens of epithelial origin
"Binding of MG2 monoclonal antibodies to rat colorectal
metastases in freshly frozen rat liver tissue"
Hybridoma Clone Antibody Isotype Cat. No.
MG1 Mouse IgG2a ARA02
MG2 Mouse IgG2a ARA10
Generation MG1 and MG2 have been raised by immunization
of mice with rat colon adenocarcinoma cells (CC531). Hybridomas were selected for
producing antibodies reacting with the CC531 cell line and with minimal cross reactivity
to normal tissues (Hagenaars et al., 2001). MG1 and MG2 belong to a second generation
of antibodies directed against tumors of epithelial origin that were strictly selected for
minimal cross reactivity with other tissues.
Reactivity
MG1 and MG2 are rat strain-independent markers for tumor cells of epithelial origin, like in
colon, breast, or lung cancer, etc. When injected in colon tumor-bearing rats, MG1
and MG2 localized to tumor cells (Hagenaars et al., 2001). MG1 and MG2 can be used
for immunohistochemical staining of tumor cells in frozen tissue sections as well as
formalin-fixed/paraffin-embedded tissue. MG1 and MG2 are also suitable to be used
in flow cytometry, Western blotting, immunoprecipitation, and ELISA.
Technical information
MG1
This monoclonal antibody recognizes a cell surface structure of about 80 kD expressed
by rat tumor cells of epithelial origin. It is useful for in vivo applications as it has no detectable
binding to other cell types then tumor cells when injected in rats. MG1 is also useful for
immunohistochemical detection of tumor cells. In immunohistochemical stainings, there
is some background in thymus and lymph nodes. Citric acid or EDTA pretreatment is
recommended for formalin-fixed/paraffin-embedded tissue sections.
MG2
This monoclonal antibody has the same characteristics as MG1.
References
1. Hagenaars M, Ensink NG, Basse P, Hokland M, Nannmark U, Eggermont AM,
Van De Velde CJ, Fleuren GJ, Kuppen PJ (2000) The microscopic anatomy of experimental
rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis
18: 189-196.
2. Hagenaars M, Ensink NG, Van Eendenburg JD, Van Vlierberghe RL, Eggermont AM,
Van De Velde CJ, Fleuren GJ, Kuppen PJ (2001) The development of novel mouse
monoclonal antibodies against the CC531 rat colon adenocarcinoma. Clin Exp Metastasis,
18: 281-289.
Ordering Information
|